Skip to main content
Advertisement
Advertisement

QNRX

QNRX logo

Quoin Pharmaceuticals, Ltd. - ADR

6.90
USD
Sponsored
+0.11
+1.59%
Sep 22, 15:57 UTC -4
Closed
exchange

Pre-Market

6.74

-0.16
-2.32%

QNRX Earnings Reports

Positive Surprise Ratio

QNRX beat 16 of 24 last estimates.

67%

Next Report

Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
-$1.66
Implied change from Q2 26 (Revenue/ EPS)
--
/
-12.63%
Implied change from Q3 25 (Revenue/ EPS)
--
/
-75.26%

Quoin Pharmaceuticals, Ltd. - ADR earnings per share and revenue

On Aug 14, 2026, QNRX reported earnings of -1.90 USD per share (EPS) for Q2 26, missing the estimate of -1.64 USD, resulting in a -15.70% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -15.87% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -1.66 USD, with revenue projected to reach -- USD, implying an decrease of -12.63% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
logo
Champions Oncology, Inc.
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.01
Actual
-$0.03
Surprise
-194.12%
FAQ
For Q2 2026, Quoin Pharmaceuticals, Ltd. - ADR reported EPS of -$1.90, missing estimates by -15.7%, and revenue of $0.00, 0% as expectations.
The stock price moved down -15.87%, changed from $6.05 before the earnings release to $5.09 the day after.
The next earning report is scheduled for Nov 04, 2026.
Based on 3 analysts, Quoin Pharmaceuticals, Ltd. - ADR is expected to report EPS of -$1.66 and revenue of -- for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement